Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

UniSA PhD candidate Deepa Nakmode and Professor Sanjay Garg in the lab.A new weekly injectable drug could transform the lives ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...